Skip to search formSkip to main contentSkip to account menu

LY2196044

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

BenzylaminesNiacinamide
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.
BACKGROUND Endogenous opioid-mediated reward pathways may play a role in the development and maintenance of alcohol dependence… 
2013
2013
Investigation of clinical pharmacokinetic variability of an opioid antagonist through physiologically based absorption modeling.
Identifying the source of inter- and/or intrasubject variability in pharmacokinetics (PK) provides fundamental information in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)